Commercially Funded DSPs

Website: Find out more about this product here

Website: Find out more about how this DSP is working towards being a trusted research partner here

Report: Harnessing primary care data for clinical research and trial recruitment - Report from Newmarket Strategy, sponsored by EMIS.

Service description: Embedding clinical research in primary care - Our Recruit solution is helping to embed clinical research at the heart of patient care across the NHS, to accelerate the development of cutting-edge treatments. This free integrated platform embedded within EMIS Web surfaces patients who may meet eligibility criteria for clinical trials, and makes it quick and easy for your practice to support vital research.

Powered by EMIS-X - Recruit uses advanced analytics and algorithms powered by EMIS-X to identify potentially eligible patients in your area to participate in clinical trials. In just a few clicks, our integrated dashboard surfaces potentially eligible patients, making it quick and easy for you to invite them to take part.

Available to all GP practice customers in England, Recruit is completely free to use and simply requires activation.

(EMIS Health website)

NIHR Portfolio studies (or alternatively funded studies) utilising this DSP option:

• Study Title: Third Study of Infectious Intestinal Disease in the UK (IID3 Study)    IRAS ID:314268     CPMS:53095

• Study Website: Accessible here 

• Study Title: EXHALE 4    IRAS ID:1006597     CPMS:54535

• Study Website: Accessible here

Website: Find out more about this product here

Service description: The uMed platform helps life science clinical and medical teams recruit patients into studies and build evidence in days, not years.

• The Cohort Search results go to the Study Sponsor - uMed finds a specific cohort using de-identified health record data from across our provider network. The sponsor can choose regions or sites

• Research team at the health system review the research opportunity - uMed presents all study documentation including centralized ethics / IRB approvals so that the health system can be adopted as a study site

• Patient Engagement is the first patient contact - The access request comes from the patient’s recognized medical provider. The patient is provided a weblink to follow. No app downloads are required

• Data Collection - Data is collected directly from the patient and combined with the patient’s EHR data in a fully compliant manner to support the specific needs of each study

(uMed website)

NIHR Portfolio studies (or alternatively funded studies) utilising this DSP option:

• Study Title: HARMONIE     CPMS ID: 51978     IRAS: 1005180

• Study Website: Accessible here

• Study Title: ADAMS     CPMS ID: 50719    IRAS: 297416

• Study Website: Accessible here

Website: Find out more about this product here

Service description: The Health Improvement Network® (THIN®) is one of the most respected and reliable data sources for anonymised primary care records, representing approximately 6% of the UK population as far back as 1994.

• Population Health Management - Research that facilitates the improvement of patient care across the general population

• Primary Care Policy - Use of anonymised data to help better inform Health Authorities on how primary care services can be delivered and targeted more effectively

• Secondary Care Policy - Analysis of the effectiveness of referral and treatment pathways ensuring appropriate procedures are in place to enable transfer of a patient’s care across multiple healthcare settings

• Epidemiological Research - Understanding trends in the presence or absence of diseases and disorders and their effects on society

• Pharmacovigilance - The assessment, monitoring and prevention of adverse effects with pharmaceutical products

• Evidence for Drug Approvals - Real world data regarding the usage and potential benefits or risks of drugs

Our aim is to enable advancements in patient care and outcomes by assisting healthcare authorities, academics and research organisations and leading healthcare technology companies.

(The Health Improvement Network website)

NIHR Portfolio studies (or alternatively funded studies) utilising this DSP option:

• Study Title: RADIANT        IRAS ID: 297067

• Study Article: Accessible here

Website: Find out more about this product here

Website: Find out more about this product here (Researcher area)

Animated explainer - How patient data is protected: Accessible here

Service description: The UK’s largest ever health research programme - Our Future Health is building a community of volunteers to create an incredibly detailed picture of the nation’s health. 

How it works for researchers - The scale, depth and detail of Our Future Health will make it a world-leading resource for health research. The programme may hold the key to huge numbers of discoveries. These include:

• identifying new signals to detect diseases much earlier than is possible now

• developing new ways to predict with accuracy those at higher risk of disease

• enabling better interventions by creating more effective tools, treatments and technologies

The intention is that the Our Future Health programme will provide two main types of resource for health research: 

• a prospective observational dataset for basic science, epidemiological, discovery and aetiological research, for example on the causes and early signs of disease

• a translational research platform comprising a cohort of people who can be re-contacted for translational and implementation research

(Our Future Health website)

NIHR Portfolio studies (or alternatively funded studies) utilising this DSP option will be listed below.

Website: Find out more about this product here

Website: Find out more about this products research network here

Service description: underpinned by one technology platform, iPLATO is transforming primary care and population health through high-impact, multi-channel patient engagement. Together with innovation partners, our solutions transform overburdened and fragmented healthcare routes into streamlined digital-first patient pathways.

Our footprint...

• Over 50% of NHS Payers deploy iPLATO

• 34m Patient network

• 2,518 of GPs surgeries use iPLATO

• 2.8m Health-conscious patients on myGP app

EXAMPLE Product - myGP app: Connecting patients to NHS services - As the largest independent medical services platform in the United Kingdom, myGP® connects millions of patients to almost 50,000 clinicians and the services of tens of thousands of pharmacies. myGP acts as the digital front door for patients accessing the NHS.

(iPLATO website)

NIHR Portfolio studies (or alternatively funded studies) utilising this DSP option will be listed below.

Website: Find out more about this product here

Video: Embedding Diversity in Clinical Trials

Video: IQVIA Direct-to-patient recruitment

Service description: The difference is IQVIA Connected Intelligence™ - From complex protocols to added pressures to move faster, today’s clinical trial leaders face unprecedented challenges. With the power of IQVIA Connected Intelligence, we connect data, technology, analytics and trial expertise to help solve your biggest hurdles.

Aim higher and transform trials with Direct-to-Patient Recruitment. (See video link above)

With unprecedented patient data and insight, combined with machine learning, IQVIA Direct-to-Patient Recruitment helps eliminate obstacles that add time, cost, and uncertainty to recruitment efforts. IQVIA’s precise data modeling capability and study-specific engagement strategy makes it possible to find both site-based patients and directly identified participants outside of the site’s known population using hyper-targeted outreach campaigns.

(IQVIA Website)

NIHR Portfolio studies (or alternatively funded studies) utilising this DSP option: An example case study can be accessed here.

Website: Find out more about this product here

Service description: Combining patient data* and world class AI powered NLP to accelerate real world evidence, clinical trial optimisation and molecular characterisation of disease.

Akrivia Health enables organisations to securely work with the world’s largest and most in-depth dataset comprised of structured psychiatric data. Our platform contains over 17 billion data-points representing interactions between clinicians and their patients.

Our team of domain specialists, including AI Scientists and Clinical Annotators, support clients in understanding psychiatry clinical data and how it can be used to develop precision psychiatry models.

We are developing a global community of individuals and organisations who are thought leaders in mental illness and dementias.

• 4.6m De-identified patient records

• 15 Years of clinical interactions

• 19.5bn Clinical data points

• 900m Clinical notes

• 5m Clinical attachments

(Akrivia Health website)

NIHR Portfolio studies (or alternatively funded studies) utilising this DSP option: A researcher case study on how this resource was utilised to support the study in question can be accessed here. 

Website: Find out more about this product here

Service description: We are your one stop shop for medicines optimisation, medication terminology, and prescribing decision support. Our solutions are live in every ICS, helping to maximise patient safety and enhance clinical efficiency whilst also directly saving the NHS over £325million to date.

Whether you are looking to proactively improve the safety and effectiveness of medicines for individual patients or to improve adherence to best practice at scale, our solutions empower healthcare professionals by targeting the right information at the right user at the right point in the workflow.

We have been a trusted partner for clinical system providers for over 40 years, delivering market-leading prescribing decision support that drives measurable impact in a range of settings, including: primary care, secondary care, community pharmacy, mental health services and more.

(First DataBank website)

NIHR Portfolio studies (or alternatively funded studies) utilising this DSP option will be listed below.

Website: Find out more about this product here

Service description: A CRO that delivers everything you need to run a study start to finish. All underpinned by our risk sharing business model; fixed upfront quotes for your entire clinical study, payable upon hitting pre-agreed milestones.

• Study Startup

• Patient Recruitment

• Data Collection

• Data Delivery

We use agile in-house tech to stand up sites and studies faster. Plus we recruit patients directly using our unique access to over 30m electronic health records for quicker enrollment.

No need to stitch together multiple data tools. Our Citrus platform provides all essential data capture, management, and delivery tools you are accustomed to, but with greater efficiency and speed to capture and deliver data in one seamless platform.

(Lindus Health website)

NIHR Portfolio studies (or alternatively funded studies) utilising this DSP option: An article about a current clinical trial utilising this resource can be accessed here.

Website: Find out more about this product here

Service description: Founded in 1969, Cegedim is a global technology and services company committed to innovation. Cegedim supplies services, technological tools, specialized software, data flow management services and databases. Its offerings are targeted notably at healthcare professionals, healthcare industries, life science companies, and health insurance companies.

(Cegedim website)

NIHR Portfolio studies (or alternatively funded studies) utilising this DSP option:

• Study Title: RADIANT        IRAS ID: 297067

• Study Article: Accessible here